21 October 2013 - Deborah Wilkes
Archived
Johnson & Johnson's OTC sales in the US increased by 17.9% to US$310 million in the third quarter of 2013, as the company continued to return its recalled products to shelves.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.